Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Kaune

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Urologie (Heidelberg, Germany)|February 10, 2025
[Aggressive variant prostate cancer and transdifferentiated neuroendocrine prostate cancer: from diagnosis to therapy]Gunhild von Amsberg, Sergey Dyshlovoy, Moritz Kaune
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Advanced renal cell carcinoma - an overview of current systemic therapy]Moritz Kaune, Carsten Bokemeyer, Gunhild von Amsberg
Oncology Research and Treatment|August 10, 2025
Management of Metastatic Prostate CancerGunhild von Amsberg, Tobias Busenbender, Anja Coym, et al.
Seminars in Radiation Oncology|June 14, 2025
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy ApproachGunhild von Amsberg, Moritz Kaune, Anja Coym, et al.
International Journal of Molecular Sciences|March 10, 2022
Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 4, 2025
Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancerLina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Scientific Reports|August 9, 2020
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer propertiesSergey A Dyshlovoy, Moritz Kaune, Malte Kriegs, et al.
Biomolecules|March 19, 2020
Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle ArrestSergey A Dyshlovoy, Darya Tarbeeva, Sergey Fedoreyev, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Marine Drugs|August 28, 2019
Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their AnaloguesMaxim E Zhidkov, Polina A Smirnova, Oleg A Tryapkin, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Urologie (Heidelberg, Germany)|February 10, 2025
[Aggressive variant prostate cancer and transdifferentiated neuroendocrine prostate cancer: from diagnosis to therapy]Gunhild von Amsberg, Sergey Dyshlovoy, Moritz Kaune
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Advanced renal cell carcinoma - an overview of current systemic therapy]Moritz Kaune, Carsten Bokemeyer, Gunhild von Amsberg
Oncology Research and Treatment|August 10, 2025
Management of Metastatic Prostate CancerGunhild von Amsberg, Tobias Busenbender, Anja Coym, et al.
Seminars in Radiation Oncology|June 14, 2025
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy ApproachGunhild von Amsberg, Moritz Kaune, Anja Coym, et al.
International Journal of Molecular Sciences|March 10, 2022
Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 4, 2025
Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancerLina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Scientific Reports|August 9, 2020
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer propertiesSergey A Dyshlovoy, Moritz Kaune, Malte Kriegs, et al.
Biomolecules|March 19, 2020
Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle ArrestSergey A Dyshlovoy, Darya Tarbeeva, Sergey Fedoreyev, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Marine Drugs|August 28, 2019
Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their AnaloguesMaxim E Zhidkov, Polina A Smirnova, Oleg A Tryapkin, et al.
Pageof 2